Ibrutinib–rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial

Authors: Wang, Michael L ^*, Jain, Preetesh, Zhao, Shuangtao, Lee, Hun Ju, Nastoupil, Loretta, Fayad, Luis, Ok, Chi Young, Kanagal-Shamanna, Rashmi, Hill, Holly A, Yao, Yixin, Hagemeister, Fredrick B, Westin, Jason R, Fowler, Nathan, Samaniego, Felipe, Steiner, Raphael, Nair, Ranjit, Iyer, Swaminathan P, Navsaria, Lucy, Badillo, Maria, Feng, Lei, Xuelin, Huang, Nogueras Gonzalez, Graciela M, Xu, Guofan, Wagner-Bartak, Nicolaus, Thirumurthi, Selvi, Santos, David, Tang, Guilin, Lin, Pei, Wang, Sa A, Jorgensen, Jeff, Yin, C Cameron, Li, Shaoying, Patel, Keyur P, Vega, Francisco, Medeiros, L Jeffery, Flowers, Christopher R, Wang, Linghua

Source: In The Lancet Oncology March 2022 23(3):406-415

CAR-T and other adoptive cell therapies for B cell malignancies

Authors: Lu, Peihua, Hill, Holly A., Navsaria, Lucy J., Wang, Michael L.

Source: In Journal of the National Cancer Center September 2021 1(3):88-96

Actinic Keratosis Incidence in Solid Organ Transplant Recipients.

Authors: Navsaria, Lucy J., Liao, Kaiping, Veerabagu, Surya, Hinkston, Candice L., Wehner, Mackenzie R.

Source: JAMA Dermatology; Mar2025, Vol. 161 Issue 3, p334-336, 3p

Internal Cancers in Solid Organ Transplant Recipients with a Post-Transplant Skin Cancer: A Cohort Study

Authors: Navsaria, Lucy J. ¹, Li, Yao ¹, Jambusaria, Anokhi ², Wheless, Lee E. ^{3, 4, 5}, Wehner, Mackenzie R. ^{1, 6, ∗}

Source: In Journal of Investigative Dermatology

Allogeneic Hematopoietic Stem Cell Transplant Recipients and Skin Cancer Risk: A Commercial Claims Cohort Study

Authors: Mohr, Cassandra ¹, Li, Yao ², Navsaria, Lucy J. ², Hinkston, Candice L. ², Wehner, Mackenzie R. ^{2, 3, ∗}

Source: In Journal of Investigative Dermatology

Skin cancer risk in patients with BRCA mutations

Authors: Navsaria, Lucy J., Haas, Allen M., Corredor, Jessica L., Arun, Banu K., Giordano, Sharon H., Nead, Kevin T., Wehner, Mackenzie R.

Source: In JAAD International December 2024 17:175-177

Dermatology Healthcare Utilization in Solid-Organ Transplant Recipients: A Retrospective Cohort Study

Authors: Stender, Carly F., Navsaria, Lucy J., Niu, Jiangong, Khalfe, Nasim, Hinkston, Candice L., Giordano, Sharon H., Wehner, Mackenzie R.

Source: In Journal of Investigative Dermatology February 2024 144(2):419-422

Skin Cancers in Medicare Beneficiaries With Actinic Keratoses.

Authors: Mohr, Cassandra, Li, Yao, Navsaria, Lucy J., Hinkston, Candice L., Shete, Sanjay S., Margolis, David J., Wehner, Mackenzie R.

Source: JAMA Dermatology; Dec2023, Vol. 159 Issue 12, p1368-1372, 5p

Repeated Encounters for Actinic Keratoses in Medicare Patients: A Retrospective Cohort Study

Authors: Khalfe, Nasim, Navsaria, Lucy J., Li, Yao, Nowakowska, Malgorzata K., Stender, Carly F., Hinkston, Candice L., Giordano, Sharon H., Shete, Sanjay S., Wehner, Mackenzie R.

Source: In Journal of Investigative Dermatology

Second Cancers in a Patient with Gastric MALT Lymphoma.

Authors: Navsaria, Lucy¹ (AUTHOR), Badillo, Alfonso¹ (AUTHOR), Wang, Michael¹ (AUTHOR)

Source: Case Reports in Medicine. 5/14/2020, p1-4. 4p.

Subject Terms: *MUCOSA-associated lymphoid tissue lymphoma, *CANCER patients, *STOMACH cancer, *LYMPHOID tissue, *LYMPHOMAS

Melanoma risk in skin of colour patients with a history of a keratinocyte carcinoma.

Authors: Mohr, Cassandra, Li, Yao, Navsaria, Lucy J, Hinkston, Candice L, Margolis, David J, Wehner, Mackenzie R

Source: British Journal of Dermatology; Mar2024, Vol. 190 Issue 3, p449-451, 3p

Subject Terms: SKIN cancer, KERATINOCYTES, MELANOMA, CARCINOMA, MOHS surgery, HEALTH maintenance organizations

Anatomic Locations of Procedurally Treated Keratinocyte Carcinomas in the US Medicare Population.

Authors: Navsaria, Lucy J., Li, Yao, Tripathy, Sanjna, Cox, Madisyn L., Hinkston, Candice L., Margolis, David J., Wehner, Mackenzie R.

Source: JAMA Dermatology; Jun2023, Vol. 159 Issue 6, p643-647, 5p

Keratinocyte Carcinoma Incidence by Race and Ethnicity in Older Adults With Medicare Coverage.

Authors: Navsaria, Lucy J., Li, Yao, Tripathy, Sanjna, Mohr, Cassandra A., Hinkston, Candice L., Margolis, David J., Wehner, Mackenzie R.

Source: JAMA Dermatology; Jan2024, Vol. 160 Issue 1, p109-111, 3p

42990 Sun protection awareness, habits, and recommendations of USA Swimming coaches

Authors: Cox, Madisyn, Hinkston, Candice, Tripathy, Sanjna, Navsaria, Lucy, Li, Yao, Nead, Kevin, Wehner, Mackenzie

Source: In Journal of the American Academy of Dermatology September 2023 89(3) Supplement:AB89-AB89

Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma.

Authors: Jain, Preetesh¹ (AUTHOR), Zhao, Shuangtao² (AUTHOR), Lee, Hun Ju¹ (AUTHOR), Hill, Holly A¹ (AUTHOR), Ok, Chi Young³ (AUTHOR), Kanagal-Shamanna, Rashmi³ (AUTHOR), Hagemeister, Fredrick B¹ (AUTHOR), Fowler, Nathan¹ (AUTHOR), Fayad, Luis¹ (AUTHOR), Yao, Yixin¹ (AUTHOR), Liu, Yang¹ (AUTHOR), Moghrabi, Omar B¹ (AUTHOR), Navsaria, Lucy¹ (AUTHOR), Feng, Lei⁴ (AUTHOR), Nogueras Gonzalez, Graciela M⁴ (AUTHOR), Xu, Guofan⁵ (AUTHOR), Thirumurthi, Selvi⁶ (AUTHOR), Santos, David⁷ (AUTHOR), Iliescu, Cezar⁸ (AUTHOR), Tang, Guilin³ (AUTHOR)

Source: Journal of Clinical Oncology. 1/10/2022, Vol. 40 Issue 2, p202-212. 11p.

Incidence and Treatment of Actinic Keratosis in Older Adults With Medicare Coverage.

Authors: Navsaria, Lucy J., Li, Yao, Nowakowska, Malgorzata K., Hinkston, Candice L., Wheless, Lee, Giordano, Sharon H., Wehner, Mackenzie R.

Source: JAMA Dermatology; Sep2022, Vol. 158 Issue 9, p1076-1078, 3p

Ibrutinib Plus Rituximab and Venetoclax (IRV) Followed By Risk-Stratified Observation or Short Course R-Hypercvad/MTX in Young Patients with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-2 Clinical Trial

Authors: Wang, Michael, Jain, Preetesh, Lee, Hun Ju, Ok, Chi Young, Hill, Holly, Navsaria, Lucy, Kanagal-Shamanna, Rashmi, Malpica-Castillo, Luis, Nair, Ranjit, Iyer, Swaminathan Padmanabhan, Samaniego, Felipe, Chen, Wendy, Oriabure, Onyeka, Feng, Lei, Thirumurthi, Selvi, Santos, David, Tang, Guilin, Vega, Francisco, Li, Shaoying, Avellaneda, Michelle, Badillo, Maria, Flowers, Christopher R.

Source: In Blood 23 November 2021 138 Supplement 1:3525-3525

Immune-Depleted Tumor Microenvironment Signature Is Associated with BTK Inhibitor Resistance in Mantle Cell Lymphoma

Authors: Jain, Preetesh, Nomie, Krystle, Segodin, Vitaly, Egorov, Evgeniy, Yao, Yixin, Navsaria, Lucy, Hill, Holly, Kotlov, Nikita, Kanagal-Shamanna, Rashmi, Ok, Chi Young, Vega, Francisco, Li, Shaoying, Che, Yuxuan, Li, Yijing, Svekolkin, Viktor, Bagaev, Alexander, Frenkel, Felix, Attaulakhanov, Ravshan, Fowler, Nathan H., Flowers, Christopher R., Wang, Michael

Source: In Blood 23 November 2021 138 Supplement 1:1321-1321

Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib.

Authors: Jain, Preetesh, Kanagal‐Shamanna, Rashmi, Zhang, Shaojun, OK, Chi Young, Navsaria, Lucy, Nastoupil, Loretta, Lee, Hun Ju, Tang, Guilin, Yin, C. Cameron, Badillo, Maria, Nair, Ranjit, Li, Shaoying, Patel, Keyur M., Flowers, Christopher, Vega, Francisco, Wang, Linghua, Wang, Michael L.

Source: American Journal of Hematology; May2021, Vol. 96 Issue 5, pE137-E140, 4p

Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy.

Authors: Jain, Preetesh, Nastoupil, Loretta, Westin, Jason, Lee, Hun Ju, Navsaria, Lucy, Steiner, Raphael E., Ahmed, Sairah, Moghrabi, Omar, Oriabure, Onyeka, Chen, Wendy, Badillo, Maria, Flowers, Christopher R., Wang, Michael L.

Source: British Journal of Haematology; Jan2021, Vol. 192 Issue 2, pe38-e42, 5p

Subject Terms: MANTLE cell lymphoma, BILIARY atresia